BioSpace News Archive

Drug Development

EIP Pharma Publishes Translational Data of Preclinical and Phase 2a Results for Neflamapimod in Dementia with Lewy Bodies: Nature Communications

EIP Pharma Inc. announced publication of an article in Nature Communications showing translational results from preclinical animal models to an exploratory, placebo-controlled clinical trial of neflamapimod in patients with mild to moderate Dementia with Lewy Bodies.

September 21, 2022
·
6 min read
Pharm Country

Allelica Launches Ancestry-Specific Polygenic Risk Score Tests for Common Diseases as a Laboratory-Developed Test

The clinical-grade, laboratory-developed test for polygenic risk score for coronary artery disease, breast cancer, prostate cancer, Type 2 Diabetes, and Alzheimer’s disease is now available for purchase direct from Allelica.

September 21, 2022
·
4 min read
Business

Adapsyn Bioscience enters into strategic collaboration with Evotec

Adapsyn Bioscience Inc. today announced a strategic collaboration with Evotec SE.

September 21, 2022
·
3 min read
Business

uLab™ hires Jeffrey Lord as Senior Vice President of Sales, North America

uLab Systems™ has announced that Jeffrey Lord has joined the company as senior vice president of sales for North America.

September 21, 2022
·
2 min read
Business

Carmot Therapeutics Announces Significant Leadership Team Expansion with Anne Phillips, MD, FRCPC Previously SVP Novo Nordisk, Joining the Board of Directors and Heather Turner, J.D. Joining as COO

Carmot Therapeutics, Inc. announced today an expansion of its Board of Directors and executive leadership team.

September 21, 2022
·
4 min read
Business

S2 Genomics Announces New Distribution Partnership to Advance Single Cell Research for the Singulator™ 100 System with Proteigene in France

S2 Genomics, Inc. announced today that it has entered into a distribution agreement with Proteigene for the promotion, sales, and support of S2’s Singulator™ 100 System and associated products for single-cell genomics and cell biology applications in France.

September 21, 2022
·
2 min read
Ivory Dentin Graft™, the First and Only Dentin Graft, Receives CE Mark

Ivory Dentin Graft creates a new dentin category of graft substitutes for repair and augmentation of bone defects.

September 21, 2022
·
2 min read
FDA

Immunitas Therapeutics Receives FDA Clearance of IND Application for IMT-009 in Solid Tumors and Hematological Malignancies

Immunitas Therapeutics today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for IMT-009, a fully human monoclonal antibody against a novel immuno-oncology target CD161.

September 21, 2022
·
3 min read
Bausch + Lomb Announces Webinar for Eye Care Professionals on New AREDS2 Study Findings

Bausch + Lomb Corporation today announced that data from the National Eye Institute’s (NEI) 10-Year Follow-on Study Results of the Age-Related Eye Disease Study 2 (AREDS2).

September 21, 2022
·
6 min read
Lone Star Bio

Castle Biosciences Presents Clinical Use Scenarios for Its Diagnostic Gene Expression Profile Tests at Maui Derm NP+PA Fall 2022 Conference

Castle Biosciences, Inc. today provided a proposed framework of the Company’s diagnostic gene expression profile (GEP) tests, MyPath® Melanoma and DiffDx®-Melanoma, for use in clinical practice to help achieve personalized management and treatment plans.

September 21, 2022
·
6 min read